Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02316392 · ClinicalTrials.gov registry record
Imaging and Understanding BOS in Lung Transplantation
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 6
- Enrollment target
NCT02316392: Completed study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02316392 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02316392 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This study is a prospective, non-randomized, longitudinal, observational study that will recruit about 5 lung transplant patients per year for 3 years.
Primary Outcome
Analysis of MRI imaging to detect BOS compared to biopsy
Interventions
- DRUG Hyperpolarized Helium-3 MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-02 |
What the finished NCT02316392 record still lists
NCT02316392 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized Helium-3 MRI is the first listed.
NCT02316392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02316392 about?
NCT02316392 is a clinical study titled "Imaging and Understanding BOS in Lung Transplantation". This study is a prospective, non-randomized, longitudinal, observational study that will recruit about 5 lung transplant patients per year for 3 years.
What is the current status of trial NCT02316392?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2014-12. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02316392?
The interventions under investigation include: Hyperpolarized Helium-3 MRI (DRUG).
Who is sponsoring clinical trial NCT02316392?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia